Effects of Curcumin and Doxorubicin on the Viability of Neuroblastoma Cancer Cell Line

Basit Öğe Kaydı
dc.contributor.authorÜnlü, İlker
dc.contributor.authorÖzdemir, İlhan
dc.contributor.authorÖztürk, Şamil
dc.contributor.authorTuncer, Mehmet Cudi
dc.date.accessioned2025-02-22T14:13:31Z
dc.date.available2025-02-22T14:13:31Z
dc.date.issued2024
dc.departmentDicle Üniversitesien_US
dc.description.abstractAim: Neuroblastoma has a very important place among childhood diseases, and despite all the methods used in treatment, it is very difficult to prevent neuroblastoma invasion. The number of studies showing that curcumin, the most active component of turmeric, is not toxic, is increasing day by day. In this study, the anticancer activities of curcumin (Cur), one of the important active compounds, were demonstrated in the Neuroblastoma cancer cell line (Na2B). Method: Neuroblastoma cell line was used in the study. To determine the IC50 doses of Dox and Cur, Na2B cells line were cultivated with an automatic pipette. MTT analysis was performed to analyze cell survival (viability). Inhibition levels in the cells were determined at 24 and 48 hours. Results: While the IC50 of Na2B cell proliferation was approximately 124.5 uM at the 48th hour in Dox-treated cells, the IC50 value of Cur at the 48th hour was found to be 224.6 uM. Conclusion: These results showed that Cur could be an alternative agent in the treatment of neuroblastoma, and its fewer side effects compared to other chemotherapeutic agents such as Dox would increase its preferability.en_US
dc.identifier.doi10.36516/jocass.1520583
dc.identifier.endpage194en_US
dc.identifier.issn2667-498X
dc.identifier.issue3en_US
dc.identifier.startpage191en_US
dc.identifier.trdizinid1271177en_US
dc.identifier.urihttps://doi.org/10.36516/jocass.1520583
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1271177
dc.identifier.urihttps://hdl.handle.net/11468/30044
dc.identifier.volume7en_US
dc.indekslendigikaynakTR-Dizin
dc.language.isoenen_US
dc.relation.ispartofÇukurova Anestezi ve Cerrahi Bilimler Dergisien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKA_TR_20250222
dc.subjectMTTen_US
dc.subjectNeuroblastomaen_US
dc.subjectcanceren_US
dc.subjectcurcuminen_US
dc.subjectNa2B cell lineen_US
dc.titleEffects of Curcumin and Doxorubicin on the Viability of Neuroblastoma Cancer Cell Lineen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu